Compare Northern Trust Corporation Common Stock (NTRS) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Northern Trust Corporation Common Stock vs 10X Genomics Inc — how do they compare? Northern Trust Corporation Common Stock trades at $162.48 (market cap $29.76B), while 10X Genomics Inc trades at $72.37 (market cap $9.35B). The key difference: Northern Trust Corporation Common Stock is far larger — about 3.2× 10X Genomics Inc's market cap, and Northern Trust Corporation Common Stock pays a 2.02% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northern Trust Corporation Common Stock for 0 Days and 10X Genomics Inc for 91 Days on average.
| NTRS | TXG | |
|---|---|---|
Market Cap | $29.76B | $9.35B |
Volume | 1,427,762 | 4,039,449 |
Sector | Financials | Health |
52-Week High | $191.47 | $97.74 |
52-Week Low | $122.72 | $11.83 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | -$6.24B | $8.88B |
Dividend Yield | 2.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG (10x Genomics) trades at $71.79, down 4.52% on the day, amid a bearish technical signal. The company shows improving fundamentals with a significant reduction in net losses (-$43.54M in 2025 vs. -$183M in 2024) and positive operating cash flow of $136.05M. Recent news highlights strong demand for its new Atera spatial biology platform and a patent victory. However, valuation metrics remain elevated with a P/S of 14.86 and EV/EBITDA of 230.71.
The outlook is cautiously optimistic. Analyst consensus is mixed with a $83.30 price target implying 16% upside, but execution on Atera commercialization and sustained margin improvement are critical. Key risks include high valuation, competitive pressures, and reliance on instrument sales growth. The stock offers growth exposure to spatial biology but requires careful risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Northern Trust Corporation Common Stock
Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
